Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PAGE-5 protein pseudogene (ENSG00000232765) is a nonfunctional DNA segment in the human genome, classified as a pseudogene, meaning it resembles a functional gene (PAGE-5) but has lost its coding potential and does not produce a functional protein. Pseudogenes may arise through gene duplication or retrotransposition, but typically accumulate disabling mutations that prevent them from encoding proteins[1][2][4][6]. The PAGE-5 family (P antigen, cancer/testis antigen) members are noted for expression in cancer and testis, but the pseudogene itself is not functional, not a therapeutic target, and does not have known biological activity or established clinical relevance[5][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAGE-5 protein pseudogene (PAGE-5 pseudogene (no standard shorter abbreviation established; ENSG00000232765 is the Ensembl gene identifier)).